Literature DB >> 11336105

Effects of canrenone on aorta and right ventricle of the rat.

G Cargnelli1, L Trevisi, P Debetto, S Luciani, S Bova.   

Abstract

Canrenone is a major active metabolite of spironolactone and, in addition to the antimineralocorticoid effect, shares with the parent compound the action as a partial agonist with respect to ouabain on the Na+-K+ ATPase. We have investigated whether canrenone, through its action on Na+-K+ ATPase, reverses rat aorta contractions induced by ouabain and has vasorelaxant properties unrelated to its interaction with ouabain. Contractile responses of endothelium-deprived aorta to 1 mM ouabain, 0.1 microM phenylephrine, 10 microM serotonin, and 60 mM K+ were relaxed by canrenone (50-250 microM), with maximum inhibitions of 85.3%, 55.3%, 56.7%, and 64.2%, respectively. Canrenone shifted to the right the concentration-response curve for Ca2+ in depolarized aorta and did not affect the response to 10 mM caffeine. In rat right ventricular strips driven at 0.1 Hz, canrenone exerted negative inotropic effect. The relaxation of ouabain-induced contraction may be due, at least in part, to an interaction between canrenone and ouabain on the Na+-K+ ATPase. Inhibition of calcium entry through calcium channels either in aorta or ventricles is the most parsimonious hypothesis of mechanism underlying the effect of canrenone on contractile responses of rat aorta to agonists and high K+ and the negative inotropic effect on ventricular strips.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11336105     DOI: 10.1097/00005344-200105000-00006

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  5 in total

Review 1.  Endogenous cardiotonic steroids in kidney failure: a review and an hypothesis.

Authors:  John M Hamlyn; Paolo Manunta
Journal:  Adv Chronic Kidney Dis       Date:  2015-05       Impact factor: 3.620

2.  Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?

Authors:  Wenxia Chai; Ingrid M Garrelds; Udayasankar Arulmani; Regien G Schoemaker; Jos M J Lamers; A H Jan Danser
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

3.  The negative inotropic action of canrenone is mediated by L-type calcium current blockade and reduced intracellular calcium transients.

Authors:  A R Costa; L B Torres; E Medei; R A Ricardo; J P França; S Smaili; J H M Nascimento; M E M Oshiro; J W M Bassani; A T Ferreira; P J F Tucci
Journal:  Br J Pharmacol       Date:  2009-08-06       Impact factor: 8.739

4.  Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1.

Authors:  Larbi Amazit; Florian Le Billan; Peter Kolkhof; Khadija Lamribet; Say Viengchareun; Michel R Fay; Junaid A Khan; Alexander Hillisch; Marc Lombès; Marie-Edith Rafestin-Oblin; Jérôme Fagart
Journal:  J Biol Chem       Date:  2015-07-22       Impact factor: 5.157

Review 5.  Why are mineralocorticoid receptor antagonists cardioprotective?

Authors:  Wenxia Chai; A H Jan Danser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-10-31       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.